| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 6687946
[patent_doc_number] => 20030031671
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-13
[patent_title] => 'Methods of treating colon cancer utilizing tumor-specific antibodies'
[patent_app_type] => new
[patent_app_number] => 09/920147
[patent_app_country] => US
[patent_app_date] => 2001-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8017
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20030031671.pdf
[firstpage_image] =>[orig_patent_app_number] => 09920147
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/920147 | Methods of treating colon cancer utilizing tumor-specific antibodies | Jul 31, 2001 | Abandoned |
Array
(
[id] => 6128377
[patent_doc_number] => 20020076406
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-20
[patent_title] => 'Multivalent target binding protein'
[patent_app_type] => new
[patent_app_number] => 09/911610
[patent_app_country] => US
[patent_app_date] => 2001-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 15435
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20020076406.pdf
[firstpage_image] =>[orig_patent_app_number] => 09911610
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/911610 | Multivalent target binding protein | Jul 24, 2001 | Abandoned |
| 09/905390 | Methods for diagnosis and treatment of diseases associated with altered expression of GNAS | Jul 12, 2001 | Abandoned |
| 09/905491 | Methods for diagnosis and treatment of diseases associated with altered expression of HIPK1 | Jul 12, 2001 | Abandoned |
Array
(
[id] => 6112559
[patent_doc_number] => 20020173461
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-21
[patent_title] => 'Methods for enhancing the efficacy of cancer therapy'
[patent_app_type] => new
[patent_app_number] => 09/901812
[patent_app_country] => US
[patent_app_date] => 2001-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 47
[patent_figures_cnt] => 47
[patent_no_of_words] => 40448
[patent_no_of_claims] => 66
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0173/20020173461.pdf
[firstpage_image] =>[orig_patent_app_number] => 09901812
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/901812 | Methods for enhancing the efficacy of cancer therapy | Jul 9, 2001 | Abandoned |
| 09/807355 | Regulation of her2/neu oncogene expression by synthetic polyamides | Jul 8, 2001 | Abandoned |
Array
(
[id] => 463126
[patent_doc_number] => 07238525
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-07-03
[patent_title] => 'Strategy for leukemia therapy'
[patent_app_type] => utility
[patent_app_number] => 10/312918
[patent_app_country] => US
[patent_app_date] => 2001-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 9015
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/238/07238525.pdf
[firstpage_image] =>[orig_patent_app_number] => 10312918
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/312918 | Strategy for leukemia therapy | Jun 28, 2001 | Issued |
Array
(
[id] => 6779151
[patent_doc_number] => 20030050233
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-13
[patent_title] => 'Peptide combination for the treatment of cancer'
[patent_app_type] => new
[patent_app_number] => 09/896903
[patent_app_country] => US
[patent_app_date] => 2001-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7515
[patent_no_of_claims] => 328
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0050/20030050233.pdf
[firstpage_image] =>[orig_patent_app_number] => 09896903
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/896903 | Peptide combination for the treatment of cancer | Jun 28, 2001 | Abandoned |
Array
(
[id] => 6675009
[patent_doc_number] => 20030060612
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-27
[patent_title] => 'Compositions and methods for the diagnosis and treatment of tumor'
[patent_app_type] => new
[patent_app_number] => 09/888257
[patent_app_country] => US
[patent_app_date] => 2001-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 50212
[patent_no_of_claims] => 77
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0060/20030060612.pdf
[firstpage_image] =>[orig_patent_app_number] => 09888257
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/888257 | Compositions and methods for the diagnosis and treatment of tumor | Jun 21, 2001 | Abandoned |
Array
(
[id] => 7964117
[patent_doc_number] => 06680369
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-01-20
[patent_title] => 'Motor proteins and methods for their use'
[patent_app_type] => B2
[patent_app_number] => 09/883096
[patent_app_country] => US
[patent_app_date] => 2001-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 15
[patent_no_of_words] => 18873
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/680/06680369.pdf
[firstpage_image] =>[orig_patent_app_number] => 09883096
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/883096 | Motor proteins and methods for their use | Jun 14, 2001 | Issued |
Array
(
[id] => 485077
[patent_doc_number] => 07217532
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-05-15
[patent_title] => 'Methods for detecting DNA damage and screening for cancer therapeutics'
[patent_app_type] => utility
[patent_app_number] => 10/276312
[patent_app_country] => US
[patent_app_date] => 2001-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 5
[patent_no_of_words] => 14592
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/217/07217532.pdf
[firstpage_image] =>[orig_patent_app_number] => 10276312
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/276312 | Methods for detecting DNA damage and screening for cancer therapeutics | May 29, 2001 | Issued |
Array
(
[id] => 5936911
[patent_doc_number] => 20020062010
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-23
[patent_title] => 'Method for making multispecific antibodies having heteromultimeric and common components'
[patent_app_type] => new
[patent_app_number] => 09/863693
[patent_app_country] => US
[patent_app_date] => 2001-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 28614
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0062/20020062010.pdf
[firstpage_image] =>[orig_patent_app_number] => 09863693
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/863693 | Method for making multispecific antibodies having heteromultimeric and common components | May 22, 2001 | Abandoned |
| 09/786502 | Fusion receptors specific for prostate-specific membrane antigen and uses thereof | May 17, 2001 | Abandoned |
Array
(
[id] => 173556
[patent_doc_number] => 07658935
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-09
[patent_title] => 'Methods and compositions for stimulating the immune system'
[patent_app_type] => utility
[patent_app_number] => 09/854568
[patent_app_country] => US
[patent_app_date] => 2001-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 14
[patent_no_of_words] => 6817
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 235
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/658/07658935.pdf
[firstpage_image] =>[orig_patent_app_number] => 09854568
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/854568 | Methods and compositions for stimulating the immune system | May 14, 2001 | Issued |
Array
(
[id] => 6062913
[patent_doc_number] => 20020031515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-14
[patent_title] => 'Methods of therapy for cancers characterized by overexpression of the HER2 receptor protein'
[patent_app_type] => new
[patent_app_number] => 09/855342
[patent_app_country] => US
[patent_app_date] => 2001-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14673
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20020031515.pdf
[firstpage_image] =>[orig_patent_app_number] => 09855342
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/855342 | Methods of therapy for cancers characterized by overexpression of the HER2 receptor protein | May 13, 2001 | Issued |
Array
(
[id] => 6342313
[patent_doc_number] => 20020034773
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-21
[patent_title] => 'S100 proteins and autoantibodies as serum markers for cancer'
[patent_app_type] => new
[patent_app_number] => 09/848948
[patent_app_country] => US
[patent_app_date] => 2001-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5919
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20020034773.pdf
[firstpage_image] =>[orig_patent_app_number] => 09848948
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/848948 | S100 proteins and autoantibodies as serum markers for cancer | May 3, 2001 | Abandoned |
Array
(
[id] => 650842
[patent_doc_number] => 07112419
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-09-26
[patent_title] => 'Human hepatoma associated protein and the polynucleotide encoding said polypeptide'
[patent_app_type] => utility
[patent_app_number] => 10/257124
[patent_app_country] => US
[patent_app_date] => 2001-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 7
[patent_no_of_words] => 9555
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/112/07112419.pdf
[firstpage_image] =>[orig_patent_app_number] => 10257124
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/257124 | Human hepatoma associated protein and the polynucleotide encoding said polypeptide | Apr 16, 2001 | Issued |
Array
(
[id] => 6545168
[patent_doc_number] => 20020110815
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-15
[patent_title] => 'Novel genes, compositions and methods for the identification, assessment, prevention, and therapy of human cancers'
[patent_app_type] => new
[patent_app_number] => 09/834975
[patent_app_country] => US
[patent_app_date] => 2001-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29689
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20020110815.pdf
[firstpage_image] =>[orig_patent_app_number] => 09834975
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/834975 | Novel genes, compositions and methods for the identification, assessment, prevention, and therapy of human cancers | Apr 12, 2001 | Abandoned |
Array
(
[id] => 1418244
[patent_doc_number] => 06521743
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-02-18
[patent_title] => 'Antibody against glyceraldehyde-3-phosphate dehydrogenase and use thereof'
[patent_app_type] => B1
[patent_app_number] => 09/807386
[patent_app_country] => US
[patent_app_date] => 2001-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3943
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/521/06521743.pdf
[firstpage_image] =>[orig_patent_app_number] => 09807386
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/807386 | Antibody against glyceraldehyde-3-phosphate dehydrogenase and use thereof | Apr 11, 2001 | Issued |
Array
(
[id] => 1119440
[patent_doc_number] => 06797495
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-09-28
[patent_title] => 'Somatic cells with ablated PrP gene and methods of use'
[patent_app_type] => B2
[patent_app_number] => 09/829507
[patent_app_country] => US
[patent_app_date] => 2001-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10649
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/797/06797495.pdf
[firstpage_image] =>[orig_patent_app_number] => 09829507
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/829507 | Somatic cells with ablated PrP gene and methods of use | Apr 8, 2001 | Issued |
